The 21st Century Cures Act’s Impact on Medical Devices
What You Need to Know to Thrive in 2017

Thursday, Jan. 26, 2017 · 1:30 p.m. - 3:00 p.m. EST

The passage of the 21st Century Cures Act means you will be scrambling to meet new mandates… regulations and guidances in several key areas — including data development and maintenance, technical support, clinical approvals, breakthrough devices, device inspections and reviews, and humanitarian device exemptions.

Join legal expert Jim O’Reilly on Jan. 26 for a discussion on the biggest change in the daily activities of the device regulatory community in four decades.

After this 90-minute webinar you’ll understand:

  • How Congress has thrown a curve at the FDA’s often stringent review process, enabling far easier approval for lower-risk devices
  • How to accelerate approval of your new medical devices and still stay in compliance with current FDA regulation and guidance
  • How the FDA intends to implement the new acceptance program for non-USA medical device research
  • How the FDA is likely to interpret “least burdensome review”
  • How the FDA is likely to interpret the humanitarian device exemption specifically mandated in the Cures Act
  • How to develop cutting-edge strategies to maximize the numerous opportunities for more rapid device development under the Cures Act and not fall behind your competition

Register today and learn what has changed with the 21st Century Cures Act and what you need to watch for in your submissions to the FDA.

Who Will Benefit

  • Regulatory affairs professionals
  • Product lifecycle managers
  • Approval and submissions specialists
  • Medical affairs

Webinar plus Audio CD/Transcript
Learn more

$487

add to cart

Webinar only
Learn more

$287

add to cart

24/7 Encore plus CD/Transcript
Learn more

$487

add to cart

24/7 Encore Presentation
Learn more

$287

add to cart

Audio CD/Transcript
Learn more

$287

add to cart

 

Meet Your Presenter

Jim O’Reilly

Retired Law Professor
University of Cincinnati College of Law

Longtime food and drug law professor Jim O’Reilly was quoted by the U.S. Supreme Court in a 2000 FDA medical device case as “the expert” on device law. He is the last surviving member of the small group which negotiated in 1975-76 for the Medical Device Amendments, and his 3-volume treatise for West “Food & Drug Administration” is used around the world by regulated firms. He chairs the FDA Committee of the American Bar Association and served for many years as program chair for conferences produced by the Food and Drug Law Institute. He served on the Editorial Advisory Board of FDLI’s Food and Drug Law Journal and has published 53 texts and 215 articles.

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.

Phone (703) 538-7600 | Fax (703) 538-7676 | Toll free (888) 838-5578 | Email customerservice@fdanews.com

© 2017 FDAnews